Financial Gravity Asset Management, Inc. Abiomed Inc Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$175.89 - $279.23 $0 - $0	0 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$250.96 - $284.94 $1,003 - $1,139	-4 Closed	0 $0
Q1 2019 Apr 19, 2019	SELL	$276.39 - $362.25 $35,101 - $46,005	-127 Reduced 96.95%	4 $1,000
Q3 2018 Oct 31, 2018	SELL	$354.53 - $449.75 $197,827 - $250,960	-558 Reduced 80.99%	131 $42,000
Q2 2018 Aug 14, 2018	BUY	$278.07 - $446.21 $187,697 - $301,191	675 Added 4821.43%	689 $260,000
Q1 2018 May 23, 2018	BUY	$192.49 - $295.85 $2,694 - $4,141	14 New	14 $4,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.